Catheter Precision terminates Chief Commercial Officer; CEO assumes role temporarily

Catheter Precision, Inc.

Marie-Claude Jacques' employment as CCO discontinued effective June 2, 2025.
CEO David Jenkins will serve as interim CCO until a replacement is hired.
No further details on reason for departure or timeline for search provided.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

David Jenkins

Chief Commercial Officer

VTAK · Catheter Precision, Inc.

Effective: 2025-06-02
Filed: Jun 06, 2025 23:59 UTC

Mr. David Jenkins, the Company’s Executive Chairman of the Board and Chief Executive Officer, will fill the role of Chief Commercial Officer until a replacement is engaged.

Departed

Marie-Claude Jacques

Chief Commercial Officer

VTAK · Catheter Precision, Inc.

Effective: 2025-06-02
Successor: David Jenkins
Filed: Jun 06, 2025 23:59 UTC

On June 2, 2025, Catheter Precision, Inc. (the “Company”) discontinued the employment of Marie-Claude Jacques, the Company’s Chief Commercial Officer.

Source: SEC EDGAR

accession 0001437749-25-019731

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.